World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03048981
Date of registration: 02/02/2017
Prospective Registration: Yes
Primary sponsor: Region Skane
Public title: Effects of Fish Oil on Platelet Function and Coagulation FOILP
Scientific title: Effects of Fish Oil on Platelet Function and Coagulation
Date of first enrolment: March 1, 2017
Target sample size: 12
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03048981
Study type:  Interventional
Study design:  Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Sweden
Contacts
Name:     Thomas Kander, MD, Phd
Address: 
Telephone:
Email:
Affiliation:  Dept. of Clinical Sciences, Lund University, SWEDEN
Key inclusion & exclusion criteria

Inclusion Criteria:

- Non smoking healthy volunteers with written consent to participate

Exclusion Criteria:

- Medication affecting coagulation or platelets within 14 days priori to inclusion



Age minimum: 19 Years
Age maximum: 60 Years
Gender: All
Health Condition(s) or Problem(s) studied
Platelet Aggregation, Spontaneous
Atherosclerosis
Surgery
Intervention(s)
Drug: Fish oil
Primary Outcome(s)
Thrombocyte aggregation measured with Cellix's microfluidic pumps and biochips [Time Frame: Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline]
Thrombocyte aggregation measured with multiple electrode aggregometry [Time Frame: Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline]
Secondary Outcome(s)
Coagulation measured with the viscohemostatic instrument and Sonoclot [Time Frame: Change of coagulation directly after intake period of 7 days compared to baseline]
Coagulation measured with the viscohemostatic instrument ROTEM [Time Frame: Change of coagulation directly after intake period of 7 days compared to baseline]
Secondary ID(s)
Fish oil and platelet function
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history